MENUNews Archive
Date: 02/14/2017
Nearly one-third of early stage breast cancer patients overestimate their risk of cancer recurrence — believing it to be more than double their actual risk. And that overestimation is affecting their quality of life, according to two recent studies. The good news? A more nuanced approach to doctor-patient communication may help improve patients’ understanding.
Date: 02/07/2017
Physicians often fail to recommend genetic testing for breast cancer patients at high risk for mutations associated with ovarian and other cancers, according to a new study.
Date: 02/03/2017
After a decade of using a novel approach to select patients for laryngeal cancer treatment, researchers are reporting "exceptional" survival rates nearing 80 percent, even for the most advanced patients.
Date: 01/25/2017
Cervical cancer is a preventable disease if detected on time, but it remains one of the leading causes of cancer deaths among women in Latin America, particularly women of poor and indigenous communities.
Date: 01/24/2017
Nearly half of women treated for early stage breast cancer reported at least one side effect from their treatment that was severe or very severe, a new study finds.
Date: 01/17/2017
A protein thought to fuel pancreatic cancer development plays a much more complicated role, a new study finds. PDX1 is critical for cancer growth, but blocking it may lead to more aggressive tumors.
Date: 01/11/2017
Recognizing a critical need to improve national vaccination rates for the human papillomavirus, the University of Michigan Rogel Cancer Center has again united with each of the 69 National Cancer Institute-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention.
Date: 01/09/2017
As some national guidelines now recommend against routine prostate cancer screening, the overall rate of men receiving treatment for the disease declined 42 percent, a new study finds.
Date: 01/09/2017
Researchers at the University of Michigan have had initial success in mice using nanodiscs to deliver a customized therapeutic vaccine for the treatment of colon and melanoma cancer tumors.
Date: 01/06/2017
By developing a new mouse model to study a poorly understood protein, researchers uncovered its link to metaplastic breast cancer, opening the door to better understanding of this challenging breast cancer subtype.